this, we can help). We offer excellent quality of life balance in a state of the art surgi center. The physician will perform... - Friday (no call, no nights or weekends) PTO Health, Dental, Vision matched 401K Malpractice Occurrence Requirements...
to join our established team in the East Valley. Position Details: Outpatient Only M-F 8-5, No call unless desired Outpatient services... and Neurosurgery partners Unique cases with a range of complexity Position is open for either Banner Baywood Medical Center in Mesa...
help procuring this, we can help). We offer excellent quality of life balance in a state of the art surgi center. The... a plus. Benefits: Monday - Friday (no call, no nights or weekends) 1099 or W2 preference Requirements: Unrestricted NJ...
shifts available. Position Responsibilities Process customer orders and inquiries in a collaborative callcenter using... center. Beautifully maintained walking trails. About Uline Uline is North America's leading distributor of shipping...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »